Evidence review
Compounded semaglutide: what to ask
Compounded semaglutide is not FDA-approved. The current shortage rules, pharmacy questions, dosing risks and price terms to check before paying.
Our medical guides link to published research and official medication information. Provider reviews compare published costs and terms. These source checks do not replace clinical review or advice from your healthcare professional.
What “compounded” actually tells you
Compounded semaglutide is prepared by a pharmacy rather than sold as a finished FDA-approved product. A prescription, a licensed pharmacy and a familiar ingredient do not make the finished compound FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before marketing.1
That distinction matters when a price advertisement looks like a cheaper version of Wegovy or Ozempic. You need to identify the product being prescribed, the reason for that formulation and the pharmacy dispensing it. Do not assume the evidence or instructions for an approved product automatically apply to a compounded vial, capsule or drop.
The shortage is not an open-ended permission slip
FDA declared the semaglutide injection shortage resolved in February 2025. Its April 2026 clarification says semaglutide and tirzepatide are not currently on its shortage list or 503B bulks list. Under the 503A framework, a documented prescriber determination of a change producing a significant difference for an identified patient matters; mass marketing something as “personalized” is not that determination.2 This describes FDA's published policy checked October 14, 2026, not a legal finding about every individual prescription.
A local pharmacy being out of stock is not the same as an FDA national shortage determination. Nor does adding a vitamin automatically settle the rules. Our semaglutide with B12 guide separates the nutrient question from the claim that a mixture qualifies for compounding.
Ask your prescriber which need an available approved option cannot meet. Ask the pharmacy which legal and professional requirements apply to your prescription. A general “we are compliant” badge does not explain your individual treatment decision.
The safety questions are concrete
FDA's concerns include dosing errors, products with fraudulent labels and semaglutide salt forms that differ from the active ingredient in approved products. Reports of problems are not a complete count of harm, because reporting is incomplete.1 These concerns do not prove that a particular shipment is defective, but they are reasons to demand clear product identification and access to a pharmacist.
For an injectable compound, get directions for the actual concentration and syringe you receive. The same syringe marking can represent a different amount after a pharmacy or formulation change. FDA has documented serious measurement errors with compounded semaglutide.3 Read the new-vial and pharmacy-change checklist; do not convert a dose from a social-media chart.
For drops, lozenges or capsules, ask for evidence on the finished formulation and route. An approved oral Wegovy tablet does not confer approval or equivalent absorption on a compounded sublingual product. The oral and sublingual claims guide explains what that comparison needs to show.
What a useful price comparison includes
There is no single price that tells you what a complete compounded prescription will cost. A low advertised figure may depend on product, dose, prepayment or an introductory discount. An older market-wide average cannot answer what your own treatment will cost now; request the terms for the exact offer you are considering.
Compare the charge, supply period and obligations together. Four weeks is not a calendar month: thirteen four-week cycles span 52 weeks. Ask whether medication, visits, required labs, shipping and membership are included, and whether later doses change the price. The uninsured cost guide walks through these differences.
A provider-specific review is more useful than a stale site-wide average when terms are complicated. For example, our Elara review distinguishes four-week billing from longer prepaid plans. It describes that provider's published terms, not a personalized quote or a recommendation that its compound is appropriate for you.
Before you give a card number
Request the dispensing pharmacy's name and contact, the exact formulation, the clinical reason for using it and the written total charge. Ask who teaches administration, handles new symptoms and answers after hours. Get cancellation, dispensing and refund deadlines before buying a multi-month package; stopping a subscription and refunding an already prepared prescription are separate questions.
If the answer changes between the checkout page and your consultation, ask for the current terms in writing. A low price is useful only when you can identify both what you are buying and who is responsible for your care.
Frequently asked questions
Is compounded semaglutide FDA-approved?
No. An individual prescription or a pharmacy license does not make the finished compounded medicine FDA-approved.
Did the end of the shortage ban every individual prescription?
The rules restrict essentially copied products and distinguish 503A patient-specific determinations from 503B outsourcing conditions. A prescriber and pharmacist must assess the requirements for the actual prescription; a general marketing claim cannot establish compliance.
What is the current monthly price?
There is no single complete price. Request the exact medication, dose, supply period, required fees and initial payment. A four-week charge and a calendar-month charge are different billing units.
Where this leaves you
References
- U.S. Food and Drug Administration (2026). FDA’s concerns with unapproved GLP-1 drugs used for weight loss. FDA. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- U.S. Food and Drug Administration (2026). Policies for compounders as national GLP-1 supply stabilizes: April 1, 2026 clarification. FDA. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
- U.S. Food and Drug Administration (2024). Dosing errors associated with compounded injectable semaglutide products. FDA. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
Friendly information, not a prescription. Everything on MamaGLP is here to help you understand your options and ask better questions — it is not a diagnosis, not a treatment plan, and not a nudge to start or stop anything. Only a licensed healthcare professional who knows your history and your goals can tell you what is right for you, so please talk with one before acting on a single word of this.
Keep reading
Semaglutide with B12: what does it add?
B12 may treat a deficiency, but adding it to semaglutide does not establish better weight loss, fewer side effects or an automatic compounding exception.
ReadNew GLP-1 vial? Check the concentration
The same syringe mark can contain a different amount after a refill. What to confirm with the pharmacy before using a changed compounded GLP-1 vial.
ReadCompounded oral semaglutide: check the claims
A compounded drop or dissolving tablet is not Wegovy’s approved pill. What absorption claims, trial evidence and product identity need to show.
ReadGLP-1 microdosing: evidence and open questions
Microdosing is not one standard GLP-1 regimen. Separate a cautious prescribed start from claims about tiny doses, fewer side effects and longevity.
ReadOzempic from Mexico: price, customs and fake pens
What it costs in Mexico, what U.S. law says about bringing it back, the fake pens the FDA and Cofepris have found, and how it compares with staying here.
ReadGLP-1 basics for first-timers: a warm, simple guide
New to GLP-1s? A kind, jargon-free explainer for moms: what these medications are, how they work, honest results, and their real limits.
ReadGLP-1 myths and facts: six claims worth checking
A practical fact-check of GLP-1 results, side effects, contraception, microdosing and compounded oral products, with the limits of the evidence.
ReadGLP-1 without insurance: what it really costs
Compare GLP-1 medication and visit fees, manufacturer offers, and eligible HSA/FSA expenses before choosing a self-pay plan.
ReadZepbound vs Wegovy: Which One Is Right for You?
A calm comparison of Zepbound (tirzepatide) and Wegovy (semaglutide) — results, side effects, cost, and the details that matter most to a mom.
Read